[go: up one dir, main page]

MX9207334A - NUCLEIC ACIDS PEPTIDICS AND PHARMACEUTICAL FORMULATION CONTAINING THEM - Google Patents

NUCLEIC ACIDS PEPTIDICS AND PHARMACEUTICAL FORMULATION CONTAINING THEM

Info

Publication number
MX9207334A
MX9207334A MX9207334A MX9207334A MX9207334A MX 9207334 A MX9207334 A MX 9207334A MX 9207334 A MX9207334 A MX 9207334A MX 9207334 A MX9207334 A MX 9207334A MX 9207334 A MX9207334 A MX 9207334A
Authority
MX
Mexico
Prior art keywords
peptidics
nucleic acids
pharmaceutical formulation
formulation containing
antisensitizers
Prior art date
Application number
MX9207334A
Other languages
Spanish (es)
Inventor
Stephen Andrew Thomson
Stewart Alwyn Noble
Daniel Joseph Ricca
Original Assignee
Glaxo Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Inc filed Critical Glaxo Inc
Publication of MX9207334A publication Critical patent/MX9207334A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/001—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis
    • C07K14/003—Peptide-nucleic acids (PNAs)
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G69/00—Macromolecular compounds obtained by reactions forming a carboxylic amide link in the main chain of the macromolecule
    • C08G69/02—Polyamides derived from amino-carboxylic acids or from polyamines and polycarboxylic acids
    • C08G69/08—Polyamides derived from amino-carboxylic acids or from polyamines and polycarboxylic acids derived from amino-carboxylic acids
    • C08G69/10—Alpha-amino-carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)

Abstract

La presente invención se refiere a oligómeros de ácidos nucléicos de péptidos y a su uso para afectar material genético, por ejemplo, como triplex o antisensibilizantes en el tratamiento de la enfermedad.The present invention relates to peptide nucleic acid oligomers and their use to affect genetic material, for example, as triplex or antisensitizers in the treatment of disease.

MX9207334A 1991-12-18 1992-12-16 NUCLEIC ACIDS PEPTIDICS AND PHARMACEUTICAL FORMULATION CONTAINING THEM MX9207334A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US80966191A 1991-12-18 1991-12-18

Publications (1)

Publication Number Publication Date
MX9207334A true MX9207334A (en) 1993-08-01

Family

ID=25201908

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9207334A MX9207334A (en) 1991-12-18 1992-12-16 NUCLEIC ACIDS PEPTIDICS AND PHARMACEUTICAL FORMULATION CONTAINING THEM

Country Status (10)

Country Link
EP (1) EP0618923A4 (en)
JP (1) JPH07502509A (en)
AU (2) AU3325493A (en)
CA (1) CA2125966A1 (en)
FI (1) FI942935L (en)
MX (1) MX9207334A (en)
NO (1) NO942327D0 (en)
NZ (1) NZ246473A (en)
WO (1) WO1993012129A1 (en)
ZA (1) ZA929764B (en)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6713602B1 (en) 1991-05-24 2004-03-30 Ole Buchardt Synthetic procedures for peptide nucleic acids
DK51092D0 (en) 1991-05-24 1992-04-15 Ole Buchardt OLIGONUCLEOTIDE ANALOGUE DESCRIBED BY PEN, MONOMERIC SYNTHONES AND PROCEDURES FOR PREPARING THEREOF, AND APPLICATIONS THEREOF
US6228982B1 (en) * 1992-05-22 2001-05-08 Benget Norden Double-stranded peptide nucleic acids
US5539082A (en) * 1993-04-26 1996-07-23 Nielsen; Peter E. Peptide nucleic acids
US6451968B1 (en) 1991-05-24 2002-09-17 Isis Pharmaceuticals, Inc. Peptide nucleic acids
US7223833B1 (en) 1991-05-24 2007-05-29 Isis Pharmaceuticals, Inc. Peptide nucleic acid conjugates
US6441130B1 (en) 1991-05-24 2002-08-27 Isis Pharmaceuticals, Inc. Linked peptide nucleic acids
EP1695979B1 (en) * 1991-12-24 2011-07-06 Isis Pharmaceuticals, Inc. Gapped modified oligonucleotides
US6277603B1 (en) 1991-12-24 2001-08-21 Isis Pharmaceuticals, Inc. PNA-DNA-PNA chimeric macromolecules
US5700922A (en) * 1991-12-24 1997-12-23 Isis Pharmaceuticals, Inc. PNA-DNA-PNA chimeric macromolecules
US6350853B1 (en) 1993-04-26 2002-02-26 Peter E. Nielsen Conjugated peptide nucleic acids having enhanced cellular uptake
US5527675A (en) * 1993-08-20 1996-06-18 Millipore Corporation Method for degradation and sequencing of polymers which sequentially eliminate terminal residues
DE4331012A1 (en) * 1993-09-13 1995-03-16 Bayer Ag Nucleic acid-binding oligomers with N-branching for therapy and diagnostics
JPH11503713A (en) * 1993-12-22 1999-03-30 パーセプティブ・バイオシステムズ・インコーポレーテッド Guanine synthon for peptide nucleic acid synthesis and method for preparing the same
US6133444A (en) * 1993-12-22 2000-10-17 Perseptive Biosystems, Inc. Synthons for the synthesis and deprotection of peptide nucleic acids under mild conditions
DK145493D0 (en) * 1993-12-23 1993-12-23 Dako As ANTIBODY
US5539083A (en) * 1994-02-23 1996-07-23 Isis Pharmaceuticals, Inc. Peptide nucleic acid combinatorial libraries and improved methods of synthesis
DE4408533A1 (en) * 1994-03-14 1995-09-28 Hoechst Ag PNA synthesis using a base-labile amino protecting group
DE4408534A1 (en) * 1994-03-14 1995-09-28 Hoechst Ag Substituted N-ethyl-glycine derivatives for the production of PNA and PNA / DNA hybrids
DE4408531A1 (en) * 1994-03-14 1995-09-28 Hoechst Ag PNA synthesis using an amino protecting group labile to weak acids
DE4427980A1 (en) * 1994-08-08 1996-02-15 Bayer Ag Nucleic acid binding oligomers for therapy and diagnostics
AU3999495A (en) * 1994-10-06 1996-05-02 Buchardt, Dorte Peptide nucleic acid conjugates
WO1996020212A2 (en) * 1994-12-28 1996-07-04 Buchardt, Dorte Peptide nucleic acid incorporating a chiral backbone
US6465650B1 (en) 1995-03-13 2002-10-15 Aventis Pharma Deutschland Gmbh Substituted N-ethylglycine derivatives for preparing PNA and PNA/DNA hybrids
EP0840741B1 (en) * 1995-06-07 2004-04-28 Perseptive Biosystems, Inc. Pna-dna chimeras and pna synthons for their preparation
AU7016096A (en) * 1995-10-20 1997-05-07 Trustees Of Boston University Nucleic acid clamps
DE19653646A1 (en) * 1996-12-20 1998-06-25 Hoechst Ag Substituted purine derivatives, processes for their preparation, agents containing them and their use
US6617422B1 (en) 1997-05-23 2003-09-09 Peter Nielsen Peptide nucleic acid monomers and oligomers
AU8147798A (en) * 1997-06-16 1999-01-04 University Of North Carolina At Chapel Hill, The Peptido oligonucleotides (pons) and their combinatorial libraries
AU9064598A (en) * 1998-07-10 2000-02-01 Harald Groger Precusors for pna-monomers
US6921812B1 (en) 2001-07-03 2005-07-26 Isis Pharmaceuticals, Inc. Methods of modulating pharmacokinetics of oligonucleotides
PL377342A1 (en) 2002-11-15 2006-01-23 Idenix (Cayman) Limited 2'-branched nucleosides and flaviviridae mutation
WO2007073149A1 (en) 2005-12-22 2007-06-28 Keygene N.V. Alternative nucleotides for improved targeted nucleotide exchange
WO2012113775A1 (en) 2011-02-21 2012-08-30 University Of Zurich Ankyrin g and modulators thereof for the treatment of neurodegenerative disorders
EP2971160B1 (en) 2013-03-15 2018-05-30 Bio-Rad Laboratories, Inc. Digital assays for mutation detection
WO2018175927A2 (en) * 2017-03-23 2018-09-27 Trucode Gene Repair, Inc. Peptide nucleic acid (pna) monomers with an orthogonally protected ester moiety

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3687030T2 (en) * 1985-03-15 1993-03-11 Eugene Stirchak STEREO-REGULAR POLYNUCLEOTID-BINDING POLYMERS.
DK51092D0 (en) * 1991-05-24 1992-04-15 Ole Buchardt OLIGONUCLEOTIDE ANALOGUE DESCRIBED BY PEN, MONOMERIC SYNTHONES AND PROCEDURES FOR PREPARING THEREOF, AND APPLICATIONS THEREOF

Also Published As

Publication number Publication date
AU3325493A (en) 1993-07-19
CA2125966A1 (en) 1993-06-24
NO942327D0 (en) 1994-06-17
FI942935A7 (en) 1994-07-27
FI942935A0 (en) 1994-06-17
JPH07502509A (en) 1995-03-16
NZ246473A (en) 1996-05-28
ZA929764B (en) 1993-10-13
NO942327L (en) 1994-08-17
EP0618923A4 (en) 1998-05-20
EP0618923A1 (en) 1994-10-12
FI942935L (en) 1994-07-27
WO1993012129A1 (en) 1993-06-24
AU7032596A (en) 1997-01-16

Similar Documents

Publication Publication Date Title
MX9207334A (en) NUCLEIC ACIDS PEPTIDICS AND PHARMACEUTICAL FORMULATION CONTAINING THEM
DE69428040D1 (en) ORAL PHARMACEUTICAL FORM
ES2075011T3 (en) USE OF GAMMA-HYDROXYBUTRIC ACID SALTS TO PREPARE PHARMACEUTICAL COMPOSITIONS FOR USE IN THE TREATMENT OF ALCOHOLISM, AND THE COMPOSITIONS OBTAINED.
PT693924E (en) PROCESSES FOR THE ADMINISTRATION (IN VIVO) OF BIOLOGICAL AND COMPOSITION SUBSTANCES USED IN THESE PROCESSES
PT96068A (en) PROCESS FOR THE PRODUCTION OF BIOLOGICALLY ACTIVE PROTEINS
ES2150496T3 (en) CONDENSED CYCLLOALKYLIMIDAZOPYRIDIDS.
ES2141229T3 (en) PHARMACEUTICAL PRODUCTS OF MODIFIED PROTEINS AND PEPTIDES.
DE58905028D1 (en) PHARMACEUTICAL COMBINATION PRODUCTS AND THE USE THEREOF AS AN ANTINEOPLASTIC MEDICINAL PRODUCT.
MX9206851A (en) ORGANIC SALTS OF N, N'-DIACETIL CYSTINE, PROCESS FOR ITS PREPARATION AND PHARMACEUTICAL COMPOSITION THAT CONTAINS THEM.
ES2057124T3 (en) THERAPEUTIC PRODUCT FOR THE TREATMENT OF PERI- OR POST-MENOPAUSIC STATES.
ES2194935T3 (en) STABLE PREPARATIONS OF TRANSGLUTAMINASE AND PROCEDURE FOR PREPARATION.
ES2052629T3 (en) PIRAZOLO (3,4-D) PIRIDINES, PROCEDURE FOR ITS PREPARATION AND USE AS MEDICINES.
ES2120036T3 (en) RECOMBINANT VIRUSES AND THEIR USE IN GENETIC THERAPY.
ES2178779T3 (en) NEW AMIDAS OF PIRIDIL ALCANS ACIDS AS CYTOSTATIC AGENTS AND IMMUNOSUPPRESSORS.
AR024742A1 (en) CYCLOPEPTIDIC DERIVATIVES THAT ACT AS INHIBITORS OF THE INTEGRIN ALFA v BETA 6, THE MEDICINES BASED ON THESE COMPOUNDS, THE PHARMACEUTICAL COMPOSITIONS CONTAINING AT LEAST ONE OF THESE MEDICATIONS, AND THE USE OF THESE PERMITTED PREPARATIONS.
AR013529A1 (en) RANTES AMINO-TERMINALLY TRUNCATED, DNA MOLECULES, VECTOR OF EXPRESSION, GUEST CELL, RECOMBINANT PROCESS TO PREPARE IT, ITS USE TO PREPARE A MEDICINAL PRODUCT AND COMPARISON THAT UNDERSTANDS IT.
AR035077A1 (en) VARIOUS NEUBLASTIN POLYPEPTIDES, FUSION PROTEINS, NUCLEIC ACIDS, VECTORS, HOSPED CELLS, METHODS TO PRODUCE SUCH POLYPEPTIDES, DIMERES, CONJUGATES, PHARMACEUTICAL COMPOSITIONS AND USE OF THESE MEDICINES
ATE88500T1 (en) DNA SEQUENCES CODING FOR PROTEINS WITH THE BIOLOGICAL ACTIVITY OF THE HUSI-TYPE INHIBITORS, GENETIC METHODS FOR THE PRODUCTION OF THESE PROTEINS, AND PHARMACEUTICALS CONTAINING THESE PROTEINS.
ATE365542T1 (en) LYOPHILIZABLE PHARMACEUTICAL PLACEBO COMPOSITION, PARTICULARLY BASED ON PROTEINS OR POLYPEPTIDES, TO IMIMATE A MEDICINAL PRODUCT
PT81345B (en) METHOD FOR PREPARING NEW ACTIVE PEPTIDEES ON THE CENTRAL NERVOUS SYSTEM WITH ACTION ON THE COLINERGIC SYSTEM, AND OF PHARMACEUTICAL COMPOSITIONS CONTAINING THESE COMPOUNDS
MX9301746A (en) NEW ACIDES 9-FLUORO-7-OXO-7H-PIRIDO (1,2,3, -DE) (1,4) -BENZOXACIN-6-CARBOXILICOS AND ITS ESTERS, PROCEDURE FOR THEIR PREPARATION AND DRUGS THAT CONTAIN THEM.
ES2068893T3 (en) NEW PEPTIDES, THEIR USE AS IMMUNO-SUPPRESSANTS AND PROCEDURES FOR ITS PREPARATION.
ES2073418T3 (en) NEW ORGANIC NITRATES AND PROCEDURE FOR ITS PREPARATION.
BR9807332A (en) Leishmania antigens for use in the therapy and diagnosis of leishmaniasis
ES2118248T3 (en) 9-CHLORINE-PROSTAGLANDINE ESTERS AND AMIDES AND THEIR USE TO PREPARE MEDICINES.